In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

CStone Pharmaceuticals Co. Ltd.

www.cstonepharma.com

Latest From CStone Pharmaceuticals Co. Ltd.

Bayer’s Stivarga First Drug To Enter Brain Cancer Platform Trial

GBM AGILE is the first global adaptive clinical trial platform for glioblastoma and the German group's liver and colorectal cancer drug will be the first of several therapies to be studied.

Cancer Clinical Trials

Trade War Expansion? STAR Board Aims To Keep Lucrative China Biotech IPOs At Home

China has officially unveiled its newest stock market for pre-revenue high-tech companies, already attracting ChipScreen and marking a new rival to similar bourses in the US and Hong Kong. But some are cautioning that local regulators and investors will need to step up if the so-called China Nasdaq is to gain traction.

China Financing

Asia Deal Watch: Everest Licenses Asia Rights To Calliditas’ IgA Nephropathy Candidate

While an orphan indication in the US and EU, IgAN accounts for 40% of glomerular disease in China; deal also confers rights in Hong Kong, Macau, Taiwan, Singapore. Also, Y-Biologics teams with Dualogics on bispecific antibodies for cancer.

Business Strategies Deals

BeiGene, Hengrui Among China Firms Flexing New Oncology Muscle At ASCO

In its bid to facilitate novel treatments for some of its most prevalent cancers, China is also poised to make a dent in the global oncology market through domestically originated agents, with the number of PD-1 and CAR-T therapies under clinical development already surpassing that in the US.

ASCO China
See All

Company Information

  • Industry
  • Biotechnology
    • Large Molecule
      • Antibodies
  • Pharmaceuticals
    • Vaccines
  • Therapeutic Areas
  • Cancer
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Asia
      • China
  • Company Type
  • Start-Up
  • Parent & Subsidiaries
  • CStone Pharmaceuticals Co. Ltd.
  • Senior Management
  • Frank Jiang, MD, PhD, CEO
    Richard Yeh, CFO
    Jason Yang, MD, PhD, CMO
    Bing Yuan, PhD, CBO
    Jon Wang, PhD, CSO
  • Contact Info
  • CStone Pharmaceuticals Co. Ltd.
    Phone: 512 8718 6550
    218 Xinghu St. C1 Bldg, North Block
    Suzhou Ind. Pk
    Suzhou, 215123
    China
Advertisement
Advertisement
UsernamePublicRestriction

Register